Over 40 million Americans suffer from a sleep disorder, which can cause fatigue, early morning headache, irritability, lack of concentration, and can contribute to depression, learning and memory difficulties, and sexual dysfunction.
San Jose, CA (PRWEB) May 09, 2013
Theravent, Inc., a private investment group based in San Jose, California, has acquired the assets of Ventus Medical. Theravent, Inc. will offer FDA cleared, Provent Sleep Apnea Therapy, available with a prescription, and over-the-counter Theravent Advanced Nightly Snore Therapy.
"Theravent, Inc. is committed to the uninterrupted and ongoing supply of Provent Sleep Apnea Therapy to patients and clinicians, and expanding the US introduction of Theravent Advanced Snore Therapy" said Matthew Williams, CEO & President of Theravent, Inc. "We’ve already heard from numerous patients and want to assure everyone that Provent Therapy will continue to be available as a treatment option for Obstructive Sleep Apnea (OSA)!”
Mr. Williams adds, “Over 40 million Americans suffer from a sleep disorder, and 20 million from OSA. Nasal EPAP represents a significant advancement in the treatment of sleep related breathing disorders and we are committed to the patients and clinicians using our devices on a nightly basis. We strongly believe in the clinical evidence and clinical importance of Provent Therapy as a treatment option for patients. Our intent is to ensure a continuous supply of Provent for patients and clinicians going forward.”
The company will share updates regarding the transition and the continued operations of the company in the coming weeks. Additional information on Theravent Advanced Nightly Snore Therapy and Provent Sleep Apnea Therapy, including product reviews, where to purchase, clinical data, and helpful snore and sleep apnea resources are available at theravent.com and proventtherapy.com.
Customer support is available at info(at)proventtherapy(dot)com and
About Provent Sleep Apnea Therapy
Provent Sleep Apnea Therapy is a proprietary medical device for the treatment of obstructive sleep apnea (OSA). The device has proven to be clinically effective in a series of published studies. It is an easy to use, non-invasive disposable treatment that works across mild, moderate and severe OSA. Provent Therapy utilizes nasal expiratory positive airway pressure (EPAP) to keep a patient's airway open during sleep. It incorporates a novel MicroValve design that is placed over the nostrils and secured with hypoallergenic adhesive. During inhalation, the valve opens allowing nearly unobstructed airflow. During exhalation, the valve closes, limiting airflow through small openings, which increases expiratory pressure and keeps the airway open, preventing disruption in breathing. Provent Therapy is FDA cleared, has CE marking and has been accepted onto the Australian Register of Therapeutic Goods (ARTG). For more information, please visit proventtherapy.com.
About Theravent Advanced Nightly Snore Therapy
Theravent is a new, clinically proven, over-the-counter treatment for snoring. Theravent offers a proven solution for patients whose snoring is affecting the quality of their and their partners' sleep. Used nightly, Theravent gives snorers and their partners a quiet night's sleep. Theravent uses patented MicroValve Technology, previously only available with a prescription, to target and treat snoring. During inhalation, the MicroValves open--allowing nearly unobstructed airflow. During exhalation, the MicroValves partially close, which increases expiratory pressure and keeps the airway open, preventing snoring. Theravent received FDA clearance in June of 2012. Theravent is not intended to treat obstructive sleep apnea. For more information, please visit theravent.com.